Synthesis and biological evaluation of novel 1-(4-methoxyphenethyl)-1H-benzimidazole-5-carboxylic acid derivatives and their precursors as antileukemic agents

被引:58
作者
Gowda, N. R. Thimme [1 ]
Kavitha, C. V. [2 ]
Chiruvella, Kishore K. [2 ]
Joy, Omana [2 ]
Rangappa, Kanchugarakoppal S. [1 ]
Raghavan, Sathees C. [2 ]
机构
[1] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India
[2] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India
关键词
Benzimidazole-5-carboxylic acid; Anticancer drugs; Chemotherapy; Cancer therapeutics; Apoptosis; DNA damage; VITRO ANTIPROLIFERATIVE ACTIVITY; CANCER-CELL LINES; IN-VIVO; BENZIMIDAZOLE DERIVATIVES; INHIBITORS; DNA; APOPTOSIS;
D O I
10.1016/j.bmcl.2009.06.103
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report here the synthesis and preliminary evaluation of novel 1-(4-methoxyphenethyl)-1H-benzimidazole-5-carboxylic acid derivatives 6(a-k) and their precursors 5(a-k) as potential chemotherapeutic agents. In each case, the structures of the compounds were determined by FTIR, H-1 NMR and mass spectroscopy. Among the synthesized molecules, methyl 1-(4-methoxyphenethyl)-2-(4-fluoro-3-nitrophenyl)-1H-benzimidazole-5-carboxylate (5a) induced maximum cell death in leukemic cells with an IC50 value of 3 mu M. Using FACS analysis we show that the compound 5a induces S/G2 cell cycle arrest, which was further supported by the observed down regulation of CDK2, Cyclin B1 and PCNA. The observed downregulation of proapoptotic proteins, upregulation of antiapoptotic proteins, cleavage of PARP and elevated levels of DNA strand breaks indicated the activation of apoptosis by 5a. These results suggest that 5a could be a potent anti-leukemic agent. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4594 / 4600
页数:7
相关论文
共 28 条
[21]   Synthesis of novel 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole derivatives as antiproliferative agents: A structure-activity relationship study [J].
Prasad, S. B. Benaka ;
Vinaya, K. ;
Kumar, C. S. Ananda ;
Swarup, Sanjay ;
Rangappa, K. S. .
INVESTIGATIONAL NEW DRUGS, 2009, 27 (06) :534-542
[22]   Novel 2-(substituted phenyl)benzimidazole derivatives with potent activity against IgE, cytokines, and CD23 for the treatment of allergy and asthma [J].
Richards, ML ;
Lio, SC ;
Sinha, A ;
Tieu, KK ;
Sircar, JC .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (26) :6451-6454
[23]   A novel DNA intercalator, butylamino-pyrimido[4',5':4,5]selenolo(2,3-b)quinoline, induces cell cycle arrest and apoptosis in leukemic cells [J].
Shahabuddin, M. S. ;
Nambiar, Mridula ;
Choudhary, Bibha ;
Advirao, Gopal M. ;
Raghavan, Sathees C. .
INVESTIGATIONAL NEW DRUGS, 2010, 28 (01) :35-48
[24]  
Tang DG, 1997, PROSTATE, V32, P284
[25]   DNA sequence dependent monomer-dimer binding modulation of asymmetric benzimidazole derivatives [J].
Tanious, FA ;
Hamelberg, D ;
Bailly, C ;
Czarny, A ;
Boykin, DW ;
Wilson, WD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2004, 126 (01) :143-153
[26]   Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation [J].
Thimmegowda, N. R. ;
Swamy, S. Nanjunda ;
Kumar, C. S. Ananda ;
Kumar, Y. C. Sunil ;
Chandrappa, S. ;
Yip, George W. ;
Rangappa, K. S. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (01) :432-435
[27]   Synthesis and antiparasitic activity of 1H-benzimidazole derivatives [J].
Valdez, J ;
Cedillo, R ;
Hernández-Campos, A ;
Yépez, L ;
Hernández-Luis, F ;
Navarrete-Vázquez, G ;
Tapia, A ;
Cortés, R ;
Hernández, M ;
Castillo, R .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (16) :2221-2224
[28]   Trends in leukemia incidence and survival in the United States (1973-1998) [J].
Xie, Y ;
Davies, SM ;
Xiang, Y ;
Robison, LL ;
Ross, JA .
CANCER, 2003, 97 (09) :2229-2235